Literature DB >> 2907164

Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats.

F Gilbert1, C T Dourish, C Brazell, S McClue, S M Stahl.   

Abstract

Various putative agonists of the 5-HT1A receptor subtype induce feeding in rats, probably by activating raphé somatodendritic 5-HT autoreceptors. These drugs also produce a marked increase in plasma concentrations of corticotropin (ACTH). In the present experiment we attempted to localize the site of action of 5-HT1A agonists on the secretion of ACTH and examined the relationship between 5-HT1A agonist-induced feeding and ACTH secretion. Rats were injected with either the high affinity 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) (0.016-1.0 mg/kg, s.c.) or the novel anxiolytics buspirone, gepirone or ipsapirone (2.0-16.0 mg/kg, s.c.), and either had their food intake measured 2 hr post injection or were sacrificed 30-40 min post injection for measurement of plasma ACTH. Plasma ACTH also was measured in rats pretreated with the serotonin synthesis inhibitor, para-chlorophenylalanine (PCPA) for three days (150 mg/kg, i.p. per day) and subsequently injected with 8-OH-DPAT (0.3 mg/kg, s.c.). As previously reported, the 5-HT1A agonists increased both food agonists increased both food intake and plasma ACTH concentrations. After 8-OH-DPAT, ipsapirone and gepirone the amount of food consumed was positively correlated with the concentration of plasma ACTH. No such correlation was evident following buspirone. PCPA pretreatment resulted in near total depletion of brain 5-HT content but had no effect on the ACTH rise induced by 8-OH-DPAT. Therefore, in contrast to the presynaptic site previously proposed for 5-HT1A agonist-induced feeding, the present results suggest a agonist-induced feeding, the present results suggest a postsynaptic location for the 5-HT1A receptor mediating ACTH release.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907164     DOI: 10.1016/0306-4530(88)90032-7

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  8 in total

Review 1.  The recombinant 5-HT1A receptor: G protein coupling and signalling pathways.

Authors:  J R Raymond; Y V Mukhin; T W Gettys; M N Garnovskaya
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 2.  Towards a serotonin-dependent leptin roadmap in the brain.

Authors:  Franck Oury; Gerard Karsenty
Journal:  Trends Endocrinol Metab       Date:  2011-05-24       Impact factor: 12.015

3.  The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone.

Authors:  P J Fletcher; M Davies
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

4.  A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure.

Authors:  Vijay K Yadav; Franck Oury; Nina Suda; Zhong-Wu Liu; Xiao-Bing Gao; Cyrille Confavreux; Kristen C Klemenhagen; Kenji F Tanaka; Jay A Gingrich; X Edward Guo; Laurence H Tecott; J John Mann; Rene Hen; Tamas L Horvath; Gerard Karsenty
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

5.  Effects of ipsapirone in healthy subjects: a dose-response study.

Authors:  R S Kahn; R Trestman; B A Lawlor; S Gabriel; M Davidson; L Siever
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

6.  Effect of m-chlorophenylpiperazine on plasma arginine-vasopressin concentrations in healthy subjects.

Authors:  R S Kahn; M A Kling; S Wetzler; G M Asnis; H van Praag
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Serotonin and the regulation of mammalian energy balance.

Authors:  Michael H Donovan; Laurence H Tecott
Journal:  Front Neurosci       Date:  2013-03-27       Impact factor: 4.677

8.  Characteristics of binding of [3H]WAY100635 to rat hippocampal membranes.

Authors:  Sven Parkel; Ago Rinken
Journal:  Neurochem Res       Date:  2006-08-26       Impact factor: 4.414

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.